Last month, the nonprofit group Public Citizen sent a letter to the U.S. Food and Drug Administration (FDA) to revisit the regulatory approval of Gilead’s…
Last year, Russia usurped Gilead’s intellectual property rights in that country in response to the worst global pandemic in the modern era. Gilead recently responded…
NeuroRx, Inc. reports today that Aviptadil, to be supplied by NeuroRx, has been identified by the National Institutes of Health (NIH) as one of two…
Although some studies have evidenced to the contrary, the anti-inflammatory drug called Actemra combined with Veklury (remdesivir) did not lead to reduced hospitalization as has…
The National Institutes of Health (NIH) along with their National Institutes of Child Health and Human Development (NICHD) and the National Institute of Allergy and…
Gilead’s inhaled version of remdesivir (Veklury) could add considerable value to the COVID-19 market. Potentially, the drug could be used in an outpatient ambulatory setting,…
The World Health Organization (WHO) has shared interim results from the international, open-label trial published recently in the New England Journal of Medicine. They report…
With the COVID-19 pandemic conditions improving in India according to some local reports, the demand for antiviral drugs Remdesivir and Favipiravir, used to treat moderate…
Much attention was placed on the antiviral drug remdesivir during the early stages of the COVID-19 pandemic. In fact, considerable public money was allocated to support…
The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institute of Health (NIH), recently produced results from a clinical trial the…
Please confirm you want to block this member.
You will no longer be able to:
Please note: This action will also remove this member from your connections and send a report to the site admin. Please allow a few minutes for this process to complete.
